Correcting for discounting and loss aversion in composite time trade-off

Health Economics

Apr 26

Written By Matthijs Versteegh

Quality of life

Matthijs Versteegh

Estimating Quality of Life Decrements in Oncology Using Time to Death

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020